Evaluation of risk factors for chemotherapy-induced nausea and vomiting in cisplatin and gemcitabine treatment for biliary tract cancer: acid suppressants do not prevent nausea.

Saito, Y; Takekuma, Y; Komatsu, Y; Sugawara, M

Saito, Y; Takekuma, Y; Komatsu, Y; Sugawara, M.

Affiliation

Saito Y; Department of Pharmacy, Hokkaido University, Sapporo, Japan.
Takekuma Y; Department of Pharmacy, Hokkaido University, Sapporo, Japan.
Komatsu Y; Cancer Center, Hokkaido University Hospital, Hokkaido University, Sapporo, Japan.
Sugawara M; Department of Pharmacy, Hokkaido University, Sapporo, Japan; Laboratory of Pharmacokinetics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan;, Email: msuga@med.hokudai.ac.jp.

Pharmazie ; 77(6): 196-201, 2022 06 01.

Article in En | MEDLINE | ID: mdl-35751163

Subject(s)

Antiemetics; Antineoplastic Agents; Biliary Tract Neoplasms; Anorexia/chemically induced; Antiemetics/therapeutic use; Antineoplastic Agents/adverse effects; Biliary Tract Neoplasms/chemically induced; Biliary Tract Neoplasms/drug therapy; Cisplatin; Deoxycytidine/analogs & derivatives; Female; Humans; Nausea/chemically induced; Nausea/drug therapy; Nausea/prevention & control; Risk Factors; Vomiting/chemically induced; Vomiting/prevention & control; Gemcitabine

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biliary Tract Neoplasms / Antiemetics / Antineoplastic Agents Type of study: Etiology_studies / Guideline / Risk_factors_studies Limits: Female / Humans Language: En Journal: Pharmazie Journal subject: FARMACIA Year: 2022 Document type: Article Affiliation country: Japan Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google